Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs

FEMS Immunology and Medical Microbiology

Volumn 59, Issue 3, 2010, Pages 466-469

  Cafiso, Viviana ^a   Bertuccio, Taschia ^a   Spina, Daniela ^a   Purrello, Simona ^a   Stefani, Stefania ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

in vitro antibiofilm tests; Staphylococcus aureus; tigecycline

Indexed keywords

DAPTOMYCIN; LEVOFLOXACIN; LINEZOLID; RIFAMPICIN; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; MINOCYCLINE;

ARTICLE; BIOFILM; DRUG CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM BIOFILM ERADICATION CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; BACTERIUM ADHERENCE; COMPARATIVE STUDY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MINOCYCLINE; STAPHYLOCOCCAL INFECTIONS;

EID: 77954628402     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00701.x     Document Type: Article

References (23)

1. Cafiso V, Bertuccio T, Santagati M, Demelio V, Spina D, Nicoletti G Stefani S (2007) agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus. FEMS Immunol Med Mic 51 : 220 227.
2. Ceri H, Olson ME, Stremick C, Read RR, Morck D Buret A (1999) The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37 : 1771 1776.
3. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22 : 996 1006.
4. Clinical and Laboratory Standard Institute (CLSI) (2009) Performance Standard for Antimicrobial Susceptibility Testing. CLSI M100 and S19 Vol. 29 n. 3. CLSI
5. Costerton JW, Stewart PS Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 21 : 1318 1322.
6. Dong Y, Zhao X, Domagala J Drlica K (1999) Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob Agents Ch 43 : 1756 1758.
7. Donlan RM Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 : 167 193.
8. Hajdu S, Lassnigg A, Graninger W, Hirschl AM Presterl E (2009) Effects of vancomycin, daptomycin, fosfomycin, tigecycline and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthop Res 27 : 1361 1365.
9. Hall-Stoodley L, Costerton JW Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2 : 95 108.
10. Harrison JJ, Turner RJ, Marques LR Ceri H (2005) Biofilms: a new understanding of these microbial communities is driving a revolution that may transform the science of microbiology. Am Sci 93 : 508 551.
11. Labthavikul P, Petersen PJ Bradford PA (2003) In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Ch 47 : 3967 3969.
12. Mah TF O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9 : 34 39.
13. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS O'Toole GA (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426 : 306 310.
14. Patel R (2005) Biofilms and antimicrobial resistance. Clin Orthop Relat R 437 : 41 47.
15. Petersen PJ, Bradford PA, Weiss WJ, Murphy TM, Sum PE Projan SJ (2002) In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob Agents Ch 46 : 2595 2601.
16. Presterl E, Hajdu S, Lassnigg AM, Hirschl AM, Holinka J Graninger W (2009) Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Ch 53 : 3205 3210.
17. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz RT Hachem R (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Ch 51 : 1656 1660.
18. Rose WE Poppens PT (2009) Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemoth 63 : 485 488.
19. Sandoe JAT, Wysome J, West AP, Heritage J Wilcox MH (2006) Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemoth 57 : 767 770.
20. Smith K, Perez A, Ramage G, Gemmell CG Lang S (2009) Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Ag 33 : 374 378.
21. Zhao X Drlica K (2001) Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 33 : S147 S156.
22. Ziebuhr W, Krimmer V, Rachid S, Lobner I, Gotz F Hacker J (1999) A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of polysaccharide intercellular adhesin synthesis by alterning insertion and excision of the insertion sequence element IS256. Mol Microbiol 32 : 345 356.
23. Zimmerli W Ochsner PE (2003) Management of infection associated with prosthetic joints. Infection 31 : 99 108.